Literature DB >> 15661937

CCL18 is expressed in atopic dermatitis and mediates skin homing of human memory T cells.

Claudia Günther1, Concha Bello-Fernandez, Tamara Kopp, Julia Kund, Nicole Carballido-Perrig, Sonja Hinteregger, Sandra Fassl, Christoph Schwärzler, Günther Lametschwandtner, Georg Stingl, Tilo Biedermann, José M Carballido.   

Abstract

CCL18 is a human chemokine secreted by monocytes and dendritic cells. The receptor for CCL18 is not yet known and the functions of this chemokine on immune cells are not fully elucidated. In this study, we describe that CCL18 is present in skin biopsies of atopic dermatitis (AD) patients but not in normal or psoriatic skin. CCL18 was specifically expressed by APCs in the dermis and by Langerhans and inflammatory dendritic epidermal cells in the epidermis. In addition, the serum levels of CCL18 and the percentages of CCL18-producing monocyte/macrophages and dendritic cells were significantly increased in AD patients compared with healthy controls. Furthermore, we demonstrate that CCL18 binds to CLA(+) T cells in peripheral blood of AD patients and healthy individuals and induces migration of AD-derived memory T cells in vitro and in human skin-transplanted SCID mice. These findings highlight a unique role of CCL18 in AD and reveal a novel function of this chemokine mediating skin homing of a subpopulation of human memory T cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15661937     DOI: 10.4049/jimmunol.174.3.1723

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

1.  Crosstalk between keratinocytes and T cells in a 3D microenvironment: a model to study inflammatory skin diseases.

Authors:  Ellen H van den Bogaard; Geuranne S Tjabringa; Irma Joosten; Mieke Vonk-Bergers; Esther van Rijssen; Henk J Tijssen; Mirthe Erkens; Joost Schalkwijk; Hans J P M Koenen
Journal:  J Invest Dermatol       Date:  2013-10-11       Impact factor: 8.551

2.  Coming of Age--CC Chemokine Ligand 18 in ANCA-Associated Vasculitis.

Authors:  Renate Kain; Andrew J Rees
Journal:  J Am Soc Nephrol       Date:  2015-03-11       Impact factor: 10.121

Review 3.  Biomarkers of therapeutic response in patients with chronic obstructive pulmonary disease: a critical review of the literature.

Authors:  Ho Il Yoon; Don D Sin
Journal:  Drugs       Date:  2011-10-01       Impact factor: 9.546

Review 4.  T-cell positioning by chemokines in autoimmune skin diseases.

Authors:  Jillian M Richmond; James P Strassner; Kingsley I Essien; John E Harris
Journal:  Immunol Rev       Date:  2019-05       Impact factor: 12.988

5.  Genetic variation in the CCL18-CCL3-CCL4 chemokine gene cluster influences HIV Type 1 transmission and AIDS disease progression.

Authors:  William S Modi; James Lautenberger; Ping An; Kevin Scott; James J Goedert; Gregory D Kirk; Susan Buchbinder; John Phair; Sharyne Donfield; Stephen J O'Brien; Cheryl Winkler
Journal:  Am J Hum Genet       Date:  2006-05-30       Impact factor: 11.025

6.  CCL18/PARC stimulates hematopoiesis in long-term bone marrow cultures indirectly through its effect on monocytes.

Authors:  Antonia Wimmer; Sophia K Khaldoyanidi; Martin Judex; Naira Serobyan; Richard G Discipio; Ingrid U Schraufstatter
Journal:  Blood       Date:  2006-08-03       Impact factor: 22.113

7.  Up-regulation of the chemokine CCL18 by macrophages is a potential immunomodulatory pathway in cutaneous T-cell lymphoma.

Authors:  Claudia Günther; Nick Zimmermann; Nicole Berndt; Marianne Grosser; Annette Stein; Andre Koch; Michael Meurer
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

Review 8.  Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes.

Authors:  Evemie Schutyser; Ann Richmond; Jo Van Damme
Journal:  J Leukoc Biol       Date:  2005-03-22       Impact factor: 4.962

9.  Segmental allergen challenge enhances chitinase activity and levels of CCL18 in mild atopic asthma.

Authors:  M L Gavala; E A B Kelly; S Esnault; S Kukreja; M D Evans; P J Bertics; G L Chupp; N N Jarjour
Journal:  Clin Exp Allergy       Date:  2013-02       Impact factor: 5.018

10.  Dexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cells.

Authors:  Atsushi Kato; Regina T Chustz; Takahisa Ogasawara; Marianna Kulka; Hirohisa Saito; Robert P Schleimer; Kenji Matsumoto
Journal:  J Immunol       Date:  2009-06-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.